Employer Benefits: Data on employer-provided coverage for GLP-1 agonists came from the KFF 2025 Employer Health Benefits Survey
This work was partially supported by the National Natural Science Foundation of China (82273961, 82073904, 81872915 to M.-W.W., 82273985, 82121005, 81973373 to D.Y., 32200576, 32071203 to L.-H.Z., 82121005 to H.E.X
After receiving IV hydration therapy, people usually experience an immediate improvement in their symptoms, such as increased energy, improved mental clarity, and a better mood
Headache Headache is one of the most commonly reported side effects of Fluconazole
The taXonomy Pathways solution taXonomy Pathways brings closed payer claims together with lab results and EHR, including physician notes, so you can evaluate eligibility, initiation, titration, response and persistence on therapy in one researchready data set